文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱与卒中取栓结局:一项观察性队列研究

Frailty and stroke thrombectomy outcomes-an observational cohort study.
PubMed 文献 · Age Ageing · 2022-01-01

该研究纳入英国一家综合卒中中心连续接受机械取栓的175例患者,用累积缺陷衰弱指数评估卒中前衰弱(指数≥0.24)。结果显示卒中前衰弱者90天独立率更低、死亡率更高,校正年龄、基线NIHSS和溶栓后,衰弱仍独立预测不良结局,而年龄不再是预测因素。

要点

  • 卒中前衰弱在取栓患者中常见,175例中49例(28%)存在衰弱。
  • 衰弱者90天死亡47% vs 非衰弱14%,独立(mRS 0-2)18% vs 61%。
  • 校正年龄、基线NIHSS和溶栓后,衰弱仍独立预测死亡和依赖。

核心结论

  • 卒中前衰弱是机械取栓患者不良结局的重要独立预测因素。
  • 常规评估卒中前衰弱有助于取栓患者的选择决策。

研究设计与样本

  • 观察性队列研究,纳入英国一家综合卒中中心2014—2018年连续接受机械取栓的175例患者。
  • 用累积缺陷衰弱指数识别卒中前衰弱,衰弱定义为指数评分≥0.24。

主要发现

  • 175例取栓患者中识别出衰弱49例(28%)。
  • 衰弱与非衰弱患者溶栓给药率、成功再通率和发病至再通时间相似。
  • 衰弱者24小时NIHSS更高:12(IQR 8-17) vs 3(IQR 2-13),P=0.001。
  • 衰弱者90天内独立(mRS 0-2)比例更低:18% vs 61%,P<0.001。
  • 衰弱者90天内死亡比例更高:47% vs 14%,P<0.001。

关键数值与推荐

  • 衰弱定义:累积缺陷衰弱指数评分≥0.24。
  • 校正年龄、基线NIHSS和溶栓后,衰弱预测90天死亡OR 3.12(95%CI 1.32-7.4)。
  • 校正年龄、基线NIHSS和溶栓后,衰弱预测90天依赖OR 3.04(95%CI 1.10-8.44)。
  • 校正衰弱后,年龄不再是结局的预测因素。

临床怎么用

  • 对拟行机械取栓的卒中患者可常规评估卒中前衰弱,辅助患者选择决策。
  • 卒中前衰弱者取栓后90天死亡和依赖风险更高,应与家属充分沟通预后。

局限性

  • 为单中心观察性队列研究,样本量175例。
  • 卒中前衰弱仅在接受该中心直接就诊的患者中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Mechanical thrombectomy (MT) can improve outcomes following ischaemic stroke. Patient selection for MT is predominantly based on physiological and imaging parameters. We assessed whether people living with pre-stroke frailty had differing outcomes following MT. METHODS: We included consecutive patients undergoing MT at a UK comprehensive stroke centre. We calculated a cumulative deficits frailty index to identify pre-stroke frailty in those patients presenting directly to the centre. Frailty was defined as an index score ≥ 0.24. We assessed univariable and multivariable association between pre-stroke frailty and stroke outcomes. Our primary outcomes were modified Rankin Scale (mRS) and mortality at 90 days. RESULTS: Of 175 patients who underwent MT (2014-2018), we identified frailty in 49 (28%). Frail and non-frail patients had similar rates of thrombolysis administration, successful recanalization and onset to recanalization times. Those with pre-stroke frailty had higher 24 hour National Institutes of Health Stroke Scale (12(IQR: 8-17) versus 3(IQR: 2-13); P = 0.001); were less likely to be independent (mRS 0-2: 18% versus 61%; P < 0.001) and more likely to die (47% versus 14%; P < 0.001) within 90 days. Adjusting for age, baseline NIHSS and thrombolysis, frailty remained a strong, independent predictor of poor clinical outcome at 90 days (Death OR: 3.12 (95% CI: 1.32-7.4); dependency OR: 3.04 (95%CI: 1.10-8.44). Age was no longer a predictor of outcome when adjusted for frailty. CONCLUSION: Pre-stroke frailty is prevalent in real-world patients eligible for MT and is an important predictor of poor outcomes. Routine assessment of pre-stroke frailty could help decision-making around patient selection for MT.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Joyce N, Atkinson T, Mc Guire K, et al. Frailty and stroke thrombectomy outcomes-an observational cohort study. Age Ageing. 2022. PMID: 35150584. doi:10.1093/ageing/afab260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。